Cell therapies for traumatic brain injury

  • Harting M
  • Baumgartner J
  • Worth L
  • et al.
N/ACitations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Preliminary discoveries of the efficacy of cell therapy are currently being translated to clinical trials. Whereas a significant amount of work has been focused on cell therapy applications for a wide array of diseases, including cardiac disease, bone disease, hepatic disease, and cancer, there continues to be extraordinary anticipation that stem cells will advance the current therapeutic regimen for acute neurological disease. Traumatic brain injury is a devastating event for which current therapies are limited. In this report the authors discuss the current status of using adult stem cells to treat traumatic brain injury, including the basic cell types and potential mechanisms of action, preclinical data, and the initiation of clinical trials.

Cite

CITATION STYLE

APA

Harting, M. T., Baumgartner, J. E., Worth, L. L., Ewing-Cobbs, L., Gee, A. P., Day, M.-C., & Cox, C. S. (2008). Cell therapies for traumatic brain injury. Neurosurgical Focus, 24(3–4), E18. https://doi.org/10.3171/foc/2008/24/3-4/e17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free